132 related articles for article (PubMed ID: 29520401)
41. Arene-ruthenium(II) acylpyrazolonato complexes: apoptosis-promoting effects on human cancer cells.
Pettinari R; Pettinari C; Marchetti F; Skelton BW; White AH; Bonfili L; Cuccioloni M; Mozzicafreddo M; Cecarini V; Angeletti M; Nabissi M; Eleuteri AM
J Med Chem; 2014 Jun; 57(11):4532-42. PubMed ID: 24793593
[TBL] [Abstract][Full Text] [Related]
42. Influence of the Linker Length on the Cytotoxicity of Homobinuclear Ruthenium(II) and Gold(I) Complexes.
Batchelor LK; Păunescu E; Soudani M; Scopelliti R; Dyson PJ
Inorg Chem; 2017 Aug; 56(16):9617-9633. PubMed ID: 28758743
[TBL] [Abstract][Full Text] [Related]
43. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
[TBL] [Abstract][Full Text] [Related]
44. Water-soluble trithiolato-bridged dinuclear ruthenium(II) and osmium(II) arene complexes with bisphosphonate functionalized ligands as anticancer organometallics.
Riedl CA; Rosner A; Harringer S; Salomon P; Hejl M; Jakupec MA; Kandioller W; Keppler BK
J Inorg Biochem; 2021 Dec; 225():111618. PubMed ID: 34607124
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
47. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.
Čanović P; Simović AR; Radisavljević S; Bratsos I; Demitri N; Mitrović M; Zelen I; Bugarčić ŽD
J Biol Inorg Chem; 2017 Oct; 22(7):1007-1028. PubMed ID: 28695374
[TBL] [Abstract][Full Text] [Related]
48. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs.
Martínez MÁ; Carranza MP; Massaguer A; Santos L; Organero JA; Aliende C; de Llorens R; Ng-Choi I; Feliu L; Planas M; Rodríguez AM; Manzano BR; Espino G; Jalón FA
Inorg Chem; 2017 Nov; 56(22):13679-13696. PubMed ID: 29099179
[TBL] [Abstract][Full Text] [Related]
50. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
[TBL] [Abstract][Full Text] [Related]
51. Lipophilicity-antiproliferative activity relationship study leads to the preparation of a ruthenium(II) arene complex with considerable in vitro cytotoxicity against cancer cells and a lower in vivo toxicity in zebrafish embryos than clinically approved cis-platin.
Haghdoost M; Golbaghi G; Létourneau M; Patten SA; Castonguay A
Eur J Med Chem; 2017 May; 132():282-293. PubMed ID: 28371640
[TBL] [Abstract][Full Text] [Related]
52. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
[TBL] [Abstract][Full Text] [Related]
53. Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.
Kilpin KJ; Crot S; Riedel T; Kitchen JA; Dyson PJ
Dalton Trans; 2014 Jan; 43(3):1443-8. PubMed ID: 24201979
[TBL] [Abstract][Full Text] [Related]
54. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
[TBL] [Abstract][Full Text] [Related]
55. Ruthenium(II) complexes as apoptosis inducers by stabilizing c-myc G-quadruplex DNA.
Zhang Z; Wu Q; Wu XH; Sun FY; Chen LM; Chen JC; Yang SL; Mei WJ
Eur J Med Chem; 2014 Jun; 80():316-24. PubMed ID: 24793882
[TBL] [Abstract][Full Text] [Related]
56. 3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru(II)(arene) anticancer complexes with biologically active ligands.
Kurzwernhart A; Kandioller W; Enyedy ÉA; Novak M; Jakupec MA; Keppler BK; Hartinger CG
Dalton Trans; 2013 May; 42(17):6193-202. PubMed ID: 23168616
[TBL] [Abstract][Full Text] [Related]
57. A novel ruthenium(II)-polypyridyl complex inhibits cell proliferation and induces cell apoptosis by impairing DNA damage repair.
Yang Q; Zhang Z; Mei W; Sun F
J Chemother; 2014 Aug; 26(4):235-42. PubMed ID: 24070188
[TBL] [Abstract][Full Text] [Related]
58. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
[TBL] [Abstract][Full Text] [Related]
59. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
60. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
